GTCR and Corza Health-backed TachoSil completed the merger with Surgical Specialties in an $800m deal.

GTCR and Corza Health-backed TachoSil, a provider of a ready-to-use degradable surgical patch, completed the merger with Surgical Specialties, a medical technology company, from ZQ Capital, an investment and advisory firm, in an $800m deal, to create a new company, Corza Medical. "The formation of Corza Medical immediately creates a market-leading, surgical technology business that brings together brands with decades of trust and clinical relevance. Our platform of technologies and our commitment to providing exceptional service will help transform surgical outcomes and change the lives of patients around the globe, while providing a foundation for continued, long-term growth," Gregory T. Lucier, Corza Medical Chairman.